TY - JOUR
KW - DPP-4 inhibitor
KW - SGLT2 inhibitor
KW - antidiabetic drug
KW - Cohort study
KW - Observational study
AU - W. Alkabbani
AU - B. Shah
AU - A. Zongo
AU - D. Eurich
AU - M. Alsabbagh
AU - J. Gamble
AD - School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada.
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Division of Endocrinology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Faculty of Pharmacy and CHU de Quebec Research Center-Université Laval, Quebec City, Quebec, Canada.
School of Public Health, University of Alberta, Edmonton, Alberta, Canada.
AN - 37563767
BT - Diabetes Obes Metab
DO - 10.1111/dom.15241
DP - NLM
ET - 2023/08/11
LA - eng
N1 - 1463-1326
Alkabbani, Wajd
Orcid: 0000-0002-7030-0442
Shah, Baiju R
Orcid: 0000-0003-3598-3628
Zongo, Arsène
Eurich, Dean T
Alsabbagh, Mhd Wasem
Gamble, John-Michael
Orcid: 0000-0001-6891-8721
FRN 156064/Canadian Institute for Health Research/
Journal Article
England
Diabetes Obes Metab. 2023 Aug 10. doi: 10.1111/dom.15241.
PY - 2023
SN - 1462-8902
T2 - Diabetes Obes Metab
TI - Post-initiation predictors of discontinuation of the sodium-glucose cotransporter-2 inhibitors: A comparative cohort study from the United Kingdom
ER -